A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, & M. A. Proskurin. (2015). PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC.
Chicago Style (17th ed.) CitationA. S. Kolbin, I. A. Vilum, Yu. E. Balykina, and M. A. Proskurin. PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC, 2015.
MLA (9th ed.) CitationA. S. Kolbin, et al. PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC, 2015.
Warning: These citations may not always be 100% accurate.